![]() ![]() ![]() Morgan Stanley, BofA Securities, CICC, Tiger Brokers, and Snowball Securities were set to be the joint bookrunners on the deal. It had planned to list on the Nasdaq under the symbol LDOC. The Beijing, China-based company was founded in 2014 and booked $154 million in sales for the 12 months ended March 31, 2021. The company's product suite includes a digital continuous care platform for patients with critical diseases, an AI-enabled curation system for longitudinal medical data, and a precision life sciences platform for clinical research. So far this year, 31 Chinese issuers have raised $12.3 billion in US IPOs, more than all of last year, representing roughly 15% of the US IPO market by deal count and proceeds.īacked by Alibaba Health, LinkDoc Technology provides a platform that structures cancer patient data to enable precision medicine and personalized care. Days after DiDi Global's (DIDI) $4.4 billion US IPO, the regulator announced that it was pulling DiDi's app from the app store until it came under compliance with certain data security requirements, causing the stock to crash. The deal would have raised 211 million at the upper end of the indicated range. It had planned to sell 10.8 million shares between 17.50 and 19.50 each. The news comes amid China's latest crackdown of its domestic internet companies, which has most recently focused on US listings. LinkDoc filed for an initial public offering in the United States last month and was due to price its shares after the U.S. On Wednesday, LinkDoc filed an amendment where it added risks related to China's new capital markets regulation and oversight, which had been issued by the country's regulator the day before. ![]() It had filed to raise $200 million by offering 10.8 million shares at a price range of $17.50 to $19.50. Insiders and anchor investors had indicated an interest in buying 58% of the deal. The company had been expected to price its IPO on Thursday night. Prior to the float, there had been some reports that an antitrust probe could be among the risks associated with the offering and those concerns were described at the time by the company as "unsubstantiated speculation from unnamed sources".LinkDoc Technology, a Chinese healthcare data company specializing in oncology patients, postponed its IPO on Thursday. The Chinese government this weekend said that group had committed serious violations related to the collection and use of personal data, and, ordered its apps be removed from app stores in the country. Ride-hailer Didi has been under fire in the market since a Chinese authorities clampdown which saw its app banned in the immediate aftermath of its US$4.4bn IPO and US markets debut.ĭiDi shares plummeted this week after the censure. The Chinese medical data group has been working on a float, with intentions to raise US$211mln, but according to a Reuters report the IPO has been shelved. LinkDoc Technology Ltd ADR Share Price NASDAQ: LDOC Stock - UK View the real-time LinkDoc Technology Ltd ADR (LDOC) share price and assess historical data, charts, technical. LinkDoc Technology has reportedly whipped away its plans to IPO in the United States in the wake of the DiDi calamity which continues to come under scrutiny in both the East and West.
0 Comments
Leave a Reply. |